image
Penumbra, Inc. PEN
Healthcare - Medical - Devices - NYSE - US
Watchlist
$ 237.84
1.85 %
$ 9.13 B
Market Cap
273.38
P/E
FINANCIAL REPORTS

Reports

Report Date Revenue YoY Net Income YoY Operating Income YoY View
Annual Report FY 10-K 2023-12-31 24.95% 4643.16% 503.26%
Annual Report FY 10-K 2022-12-31 13.32% -76.32% -143.15%
Annual Report FY 10-K 2021-12-31 33.40% 113.62% 80.74%
Annual Report FY 10-K 2020-12-31 2.38% -39.74% -81.97%
Annual Report FY 10-K 2019-12-31 23.03% 634.10% 5676.06%
Annual Report FY 10-K 2018-12-31 33.31% 41.74% -73.13%
Annual Report FY 10-K 2017-12-31 26.75% -68.56% 186.30%
Annual Report FY 10-K 2016-12-31 41.50% 526.38% -32.30%
Annual Report FY 10-K 2015-12-31 48.27% 5.35% 38.88%
Annual Report FY 10-K 2014-12-31 41.26% -45.23% 367.23%
Annual Report FY 10-K 2013-12-31 21.47% 109.35% -32.85%
Annual Report FY 10-K 2012-12-31 0.00% 0.00% 0.00%
Quarterly Report Q3 8-K 2024-09-30 11.11% 220.46% 180.11%
Quarterly Report Q2 8-K 2024-06-30 14.49% -317.51% -22.45%
Quarterly Report Q1 8-K 2024-03-31 15.43% 28.50% 744.45%
Quarterly Report Q4 8-K 2023-12-31 28.69% 1298.45% 2278.42%
Quarterly Report Q3 8-K 2023-09-30 26.80% 505.72% 132.33%
Quarterly Report Q2 8-K 2023-06-30 25.51% 614.24% 12969.78%
Quarterly Report Q1 8-K 2023-03-31 18.39% 10737.97% 135.42%
Quarterly Report Q4 8-K 2022-12-31 8.43% 115.74% 95.99%
Quarterly Report Q3 8-K 2022-09-30 12.39% -25.66% -38.12%
Quarterly Report Q2 8-K 2022-06-30 13.07% -39.94% -1.35%
Quarterly Report Q1 8-K 2022-03-31 20.50% -99.33% -30.05%
Quarterly Report Q4 8-K 2021-12-31 22.24% -675.25% -2195.53%
Quarterly Report Q3 8-K 2021-09-30 25.84% 200.40% 143.56%
Quarterly Report Q2 8-K 2021-06-30 75.30% 177.18% 158.43%
Quarterly Report Q1 8-K 2021-03-31 23.21% 730.60% 2107.05%
Quarterly Report Q4 8-K 2020-12-31 14.89% -62.35% -16.49%
Quarterly Report Q3 8-K 2020-09-30 8.30% -76.77% -155.35%
Quarterly Report Q2 8-K 2020-06-30 -21.68% -72.10% -137.87%
Quarterly Report Q1 8-K 2020-03-31 6.92% -86.68% -94.53%
Quarterly Report Q4 8-K 2019-12-31 20.26% 45.50% 58.63%
Quarterly Report Q3 8-K 2019-09-30 24.77% 160.66% 162.24%
Quarterly Report Q2 8-K 2019-06-30 22.40% 23.97% 37.90%
Quarterly Report Q1 8-K 2019-03-31 25.06% 94.83% 175.70%
Quarterly Report Q4 8-K 2018-12-31 25.76% -26.69% 72.95%
Quarterly Report Q3 8-K 2018-09-30 33.24% -7953.78% -3052.56%
Quarterly Report Q2 8-K 2018-06-30 36.05% 958.86% 799.02%
Quarterly Report Q1 8-K 2018-03-31 40.28% 276.79% 297.70%
Quarterly Report Q4 8-K 2017-12-31 31.39% 479.09% 434.72%
Quarterly Report Q3 8-K 2017-09-30 24.89% 121.52% 150.11%
Quarterly Report Q2 8-K 2017-06-30 23.78% -842.16% -98.21%
Quarterly Report Q1 8-K 2017-03-31 26.41% -398.21% -111.50%
Quarterly Report Q4 8-K 2016-12-31 34.34% -146.72% -63.30%
Quarterly Report Q3 8-K 2016-09-30 33.27% -122.75% -62.47%
Quarterly Report Q2 8-K 2016-06-30 53.87% 106.93% 82.43%
Quarterly Report Q1 8-K 2016-03-31 48.69% -68.82% -54.01%
Quarterly Report Q4 8-K 2015-12-31 53.70% 292.55% 465.22%
Quarterly Report Q3 8-K 2015-09-30 55.30% 423.84% 601.61%
Quarterly Report Q2 8-K 2015-06-30 34.41% -3561.33% -712.71%
Quarterly Report Q1 8-K 2015-03-31 48.88% 793.57% 116.73%
Quarterly Report Q4 8-K 2014-12-31 0.00% 0.00% 0.00%
Quarterly Report Q3 8-K 2014-09-30 0.00% 0.00% 0.00%
Quarterly Report Q2 8-K 2014-06-30 0.00% 0.00% 0.00%
Quarterly Report Q1 8-K 2014-03-31 0.00% 0.00% 0.00%